• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170

4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic Acid (CAS No. 1261903-87-0): A Comprehensive Overview

4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid (CAS No. 1261903-87-0) is a compound that has garnered significant attention in recent years due to its potential applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as FHBA, is a member of the hydroxybenzoic acid family and is characterized by its unique structural features, including a fluoro-substituted phenyl group and two hydroxyl groups. These features contribute to its diverse biological activities and make it a valuable candidate for various therapeutic applications.

The chemical structure of 4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid consists of a benzene ring with a fluoro-substituted phenyl group at the para position and two hydroxyl groups, one at the meta position and one at the ortho position relative to the carboxylic acid group. This arrangement of functional groups imparts unique physicochemical properties to the molecule, such as enhanced solubility and stability, which are crucial for its potential use in drug development.

Recent studies have highlighted the pharmacological properties of 4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid. One notable area of research is its anti-inflammatory activity. In vitro studies have shown that FHBA can effectively inhibit the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), in human macrophages. This suggests that FHBA may have therapeutic potential in treating inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, 4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid has also been investigated for its antioxidant activity. Oxidative stress is a key factor in the pathogenesis of many diseases, including neurodegenerative disorders and cardiovascular diseases. Research has demonstrated that FHBA can scavenge free radicals and reduce oxidative damage in cellular models, indicating its potential as a protective agent against oxidative stress-related conditions.

The cytotoxic effects of 4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid have also been explored in cancer research. Studies have shown that FHBA can induce apoptosis in various cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism of action appears to involve the modulation of signaling pathways involved in cell proliferation and survival, such as the PI3K/Akt pathway. These findings suggest that FHBA may have potential as an anticancer agent or as a lead compound for further drug development.

Beyond its direct biological activities, 4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid has also been studied for its ability to enhance the bioavailability and efficacy of other drugs. For example, FHBA has been shown to improve the solubility and permeability of poorly soluble drugs, making it a promising candidate for use in drug delivery systems. This property could be particularly useful in improving the therapeutic outcomes of drugs with limited bioavailability.

The synthesis of 4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid has been optimized using various methodologies to ensure high yield and purity. One common approach involves the reaction of 4-fluoro-2-hydroxybenzaldehyde with 3-hydroxybenzoyl chloride followed by hydrolysis to obtain the final product. The purity of FHBA can be assessed using techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy.

In conclusion, 4-(4-Fluoro-2-hydroxyphenyl)-2-hydroxybenzoic acid (CAS No. 1261903-87-0) is a multifaceted compound with a range of potential applications in medicinal chemistry and pharmaceutical research. Its anti-inflammatory, antioxidant, and cytotoxic properties make it a valuable candidate for further investigation and development into therapeutic agents for various diseases. Additionally, its ability to enhance drug bioavailability opens up new possibilities for improving drug delivery systems. As research continues to advance, it is likely that new insights into the biological activities and mechanisms of action of FHBA will emerge, further solidifying its importance in the field.

• 22510-33-4(5-(4-fluorophenyl)-2-hydroxybenzoic acid)
• 1261890-35-0(3-(3-Fluoro-5-hydroxyphenyl)-2-methoxybenzoic acid)
• 1261905-57-0(3-(4-Fluoro-2-hydroxyphenyl)-2-methoxybenzoic acid)
• 1214367-30-2(4-(3-fluorophenyl)-2-hydroxybenzoic acid)
• 22494-43-5(3'-fluoro-4-hydroxy-3-biphenylcarboxylic Acid)
• 1261909-99-2(4-(3,5-Difluorophenyl)-2-hydroxybenzoic acid)
• 1261889-41-1(3-(4-Fluoro-2-hydroxyphenyl)benzoic acid)
• 1261898-28-5(5-(3-Carboxy-5-fluorophenyl)-2-formylphenol)
• 1261903-64-3(4-(5-Fluoro-2-hydroxyphenyl)-3-hydroxybenzoic acid)
• 67531-84-4(4-(4-Fluorophenyl)-2-hydroxybenzoic acid)